Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Trellus Health PLC (GB:TRLS)
LSE:TRLS
Holding GB:TRLS?
Track your performance easily
TRLS Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.60p - 7.38p
Previous Close0.63p
Volume494.81K
Average Volume (3M)862.56K
Market Cap
£1.01M
Enterprise Value-8.67M
Total Cash (Recent Filing)$12.17M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.26
Next Earnings
May 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding161,508,333
10 Day Avg. Volume31,820
30 Day Avg. Volume862,564
Standard Deviation0.20
R-Squared0.00080
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)5.00
Price to Sales (P/S)66.38
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-456.09
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Trellus Health PLC News
PremiumCompany Announcements
Trellus Health PLC Reports Major Shareholding Change
PremiumCompany Announcements
Trellus Health PLC Reports Major Shareholding Change
PremiumCompany Announcements
Trellus Health Optimistic Despite Slow Enrollment
PremiumCompany Announcements
Trellus Health PLC Welcomes New Board Expertise
PremiumCompany Announcements
Trellus Health Strengthens Board with New Appointment
PremiumCompany Announcements
Trellus Health to Announce Interim Results
PremiumCompany Announcements
Dowgate Group Ups Stake in Trellus Health PLCPremiumCompany Announcements
Trellus Health PLC Reports Major Holdings ShiftOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
TRLS FAQ
What was Trellus Health PLC’s price range in the past 12 months?
Trellus Health PLC lowest share price was 0.60p and its highest was 7.38p in the past 12 months.
What is Trellus Health PLC’s market cap?
Currently, no data Available
When is Trellus Health PLC’s upcoming earnings report date?
Trellus Health PLC’s upcoming earnings report date is May 13, 2025 which is in 142 days.
How were Trellus Health PLC’s earnings last quarter?
Trellus Health PLC released its earnings results on Sep 26, 2024. The company reported -0.019p earnings per share for the quarter, missing the consensus estimate of N/A by -0.019p.
Is Trellus Health PLC overvalued?
According to Wall Street analysts Trellus Health PLC’s price is currently Overvalued.
Does Trellus Health PLC pay dividends?
Trellus Health PLC does not currently pay dividends.
What is Trellus Health PLC’s EPS estimate?
Trellus Health PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Trellus Health PLC have?
Trellus Health PLC has 161,508,330 shares outstanding.
What happened to Trellus Health PLC’s price movement after its last earnings report?
Trellus Health PLC reported an EPS of -0.019p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -27.586%.
Which hedge fund is a major shareholder of Trellus Health PLC?
Currently, no hedge funds are holding shares in GB:TRLS
---
Trellus Health PLC Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.11%
12-Months-Change
Fundamentals
Return on Equity
-35.32%
Trailing 12-Months
Asset Growth
-28.68%
Trailing 12-Months
Company Description
Trellus Health PLC
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care remotely via telehealth. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
---
Technical Analysis
---